Coya Therapeutics, Inc. Common Stock (COYA) — Cash Flow Quality Index
Latest as of December 2023:
-1.77x
Coya Therapeutics, Inc. Common Stock (COYA) has a Cash Flow Quality Index of -1.77x as of December 2023. Operating cash flow of $-2.24 Million is below net income of $1.27 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Coya Therapeutics, Inc. Common Stock assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
-1.77x
Operating CF / Net Income
Operating Cash Flow
$-2.24 Million
USD
Net Income
$1.27 Million
USD
Data as of
Dec 2023
Most recent filing
Annual Cash Flow Quality Index for Coya Therapeutics, Inc. Common Stock (None–None)
Year-by-year earnings quality comparison for Coya Therapeutics, Inc. Common Stock. For live market cap and the full company financial profile, see COYA stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.